Mamta Panda

Mamta Panda

Auto-generated profile, based on publicly available information

Mamta Panda

Department of Medical Radiology & Imaging Technology Rayat Bahra University Kharar Punjab India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2025 in Journal of Radiology Nursing
Verified
Journal Article
Closed access
SBSapna Bhatt
Sapna Bhatt
MPMamta Panda
Mamta Panda
SOSantosh Ojha
Santosh Ojha
LGLalit Kumar Gupta
Lalit Kumar Gupta


6 October 2026 in Journal of Medical Imaging and Radiation Oncology
Verified
Journal Article
Closed access
PDF file
MKMwanajuma Yahya Kassim
Mwanajuma Yahya Kassim
DSDolly A Sharma
Dolly A Sharma
SSShreeni Shah
Shreeni Shah
MPMamta Panda
Mamta Panda
SOSantosh Ojha
Santosh Ojha

19 February 2026 in Journal of Radiology Nursing
Verified
Journal Article
Closed access
MPMamta Panda
Mamta Panda
SKShraddha Kumari
Shraddha Kumari
KSKritika Sharma
Kritika Sharma
VKVarshdeep Kour
Varshdeep Kour
LGLalit Kumar Gupta
Lalit Kumar Gupta

2 December 2025 in Journal of Medical Imaging and Radiation Oncology
Verified
Journal Article
Closed access
MPMamta Panda
Mamta Panda
MMMehak Manzoor
Mehak Manzoor
LGLalit Kumar Gupta
Lalit Kumar Gupta

2 April 2026 in Polish Journal of Radiology
Verified
Journal Article
Open access
PDF file
MPMamta Panda
Mamta Panda
MSMehwish Showkat
Mehwish Showkat
LGLalit Kumar Gupta
Lalit Kumar Gupta
Coronary artery disease (CAD) remains a leading cause of disability and death worldwide. Noninvasive tests are crucial to ensure early diagnosis and risk stratification. The coronary artery calcium scoring (CACS), a non-invasive measure obtained using non-contrast computed tomography, reflects the calcific plaque burden, and may provide important diagnostic and prognostic information. This study aimed to systematically review and meta-analyze the recent literature to ascertain the diagnostic and prognostic usefulness of CACS in patients with suspected or established CAD. A literature search was conducted in PubMed, Scopus, and Web of Science for studies published between 2008 and 2024. The studies were included if they evaluated the prognostic and diagnostic value of CACS, either alone or with computed tomography angiography (CTA). Data extraction was performed for pooled sensitivities and specificities, hazard ratios (HRs), and event-free survival. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) criteria were used to assess methodological quality. Fourteen high-quality studies with a total of more than 80,000 patients were meta-analyzed. Subjects with CAC ≥ 100 were at a significantly increased risk of developing major adverse cardiac events (HR 2.7; 95% confidence interval: 2.1-3.6). CACS is highly beneficial in diagnostic discrimination (pooled sensitivity 88%, specificity 77%) in those presenting with chest pain but no prior history of CAD. It is essential to emphasize that CAC score of zero correlates with the best prognosis and very low rates of clinical events across various populations, including patients with diabetes and asymptomatic individuals. The CACS fills a special niche as a very strong predictor and non-invasive marker in the diagnosis and prognosis of CAD. Combining calcium scoring with CTA benefits clinical decision-making, particularly for patients categorized as low to intermediate risk.